VANGUARD GROUP INC - TETRALOGIC PHARMACEUTICALS C ownership

TETRALOGIC PHARMACEUTICALS C's ticker is TLOG and the CUSIP is 88165U109. A total of 29 filers reported holding TETRALOGIC PHARMACEUTICALS C in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of TETRALOGIC PHARMACEUTICALS C
ValueSharesWeighting
Q3 2016$25,000
-45.7%
157,349
+5.9%
0.00%
Q2 2016$46,000
+109.1%
148,649
+21.2%
0.00%
Q1 2016$22,000
-94.3%
122,675
-44.7%
0.00%
Q4 2015$385,000
+1.9%
222,000
+10.3%
0.00%
Q3 2015$378,000
-12.7%
201,200
+8.7%
0.00%
Q2 2015$433,000
-25.3%
185,100
+39.9%
0.00%
Q1 2015$580,000
+19.6%
132,315
+31.4%
0.00%
Q4 2014$485,000
+736.2%
100,699
+618.4%
0.00%
Q3 2014$58,00014,0180.00%
Other shareholders
TETRALOGIC PHARMACEUTICALS C shareholders Q3 2015
NameSharesValueWeighting ↓
Clarus Ventures, LLC 4,644,705$19,322,0007.71%
First Washington CORP 185,250$771,0000.44%
SPHERA FUNDS MANAGEMENT LTD. 194,200$808,0000.10%
KINGDON CAPITAL MANAGEMENT, L.L.C. 286,801$1,173,0000.05%
EMERALD ADVISERS, LLC 175,000$728,0000.04%
Pine River Capital Management L.P. 209,900$873,0000.01%
Alyeska Investment Group, L.P. 79,196$329,0000.01%
HighTower Advisors, LLC 66,514$277,0000.01%
Tower Research Capital LLC (TRC) 1,441$6,0000.00%
First Eagle Investment Management, LLC 114,456$476,0000.00%
View complete list of TETRALOGIC PHARMACEUTICALS C shareholders